YH22162

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YH22162, covering 2024-11-12 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment [Phase 3]

See pricing